1-70430302-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_001902.6(CTH):c.647-15G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00143 in 1,493,734 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.0075 ( 17 hom., cov: 32)
Exomes 𝑓: 0.00074 ( 15 hom. )
Consequence
CTH
NM_001902.6 intron
NM_001902.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.789
Genes affected
CTH (HGNC:2501): (cystathionine gamma-lyase) This gene encodes a cytoplasmic enzyme in the trans-sulfuration pathway that converts cystathione derived from methionine into cysteine. Glutathione synthesis in the liver is dependent upon the availability of cysteine. Mutations in this gene cause cystathioninuria. Alternative splicing of this gene results in three transcript variants encoding different isoforms. [provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00748 (1138/152092) while in subpopulation AFR AF= 0.0254 (1056/41518). AF 95% confidence interval is 0.0242. There are 17 homozygotes in gnomad4. There are 539 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 17 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTH | NM_001902.6 | c.647-15G>C | intron_variant | ENST00000370938.8 | NP_001893.2 | |||
CTH | NM_001190463.2 | c.551-15G>C | intron_variant | NP_001177392.1 | ||||
CTH | NM_153742.5 | c.515-15G>C | intron_variant | NP_714964.2 | ||||
CTH | XM_017000416.3 | c.77-15G>C | intron_variant | XP_016855905.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTH | ENST00000370938.8 | c.647-15G>C | intron_variant | 1 | NM_001902.6 | ENSP00000359976.3 | ||||
CTH | ENST00000346806.2 | c.515-15G>C | intron_variant | 1 | ENSP00000311554.2 | |||||
CTH | ENST00000411986.6 | c.551-15G>C | intron_variant | 2 | ENSP00000413407.2 | |||||
CTH | ENST00000464926.1 | n.695-15G>C | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00749 AC: 1138AN: 151974Hom.: 17 Cov.: 32
GnomAD3 genomes
AF:
AC:
1138
AN:
151974
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00201 AC: 502AN: 250098Hom.: 7 AF XY: 0.00149 AC XY: 202AN XY: 135206
GnomAD3 exomes
AF:
AC:
502
AN:
250098
Hom.:
AF XY:
AC XY:
202
AN XY:
135206
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000744 AC: 998AN: 1341642Hom.: 15 Cov.: 22 AF XY: 0.000664 AC XY: 448AN XY: 674922
GnomAD4 exome
AF:
AC:
998
AN:
1341642
Hom.:
Cov.:
22
AF XY:
AC XY:
448
AN XY:
674922
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00748 AC: 1138AN: 152092Hom.: 17 Cov.: 32 AF XY: 0.00725 AC XY: 539AN XY: 74368
GnomAD4 genome
AF:
AC:
1138
AN:
152092
Hom.:
Cov.:
32
AF XY:
AC XY:
539
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3472
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cystathioninuria Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at